Outpatient Healthcare Settings and Transmission of Clostridium difficile

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Jury, Lucy A ^a   Sitzlar, Brett ^a   Kundrapu, Sirisha ^b   Cadnum, Jennifer L ^b   Summers, Kim M ^a   Muganda, Christine P ^c   Deshpande, Abhishek ^b   Sethi, Ajay K ^c   Donskey, Curtis J ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; BACTERIAL SPORE; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG DOSE TITRATION; EMERGENCY WARD; EXAMINATION TABLE; FECES INCONTINENCE; FEMALE; HOSPITAL BED; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PATIENT MOBILITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECURRENT INFECTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN CULTURE;

EID: 84880850664     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070175     Document Type: Article

References (19)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-455.
2. McFarland LV, Mulligan ME, Kwok RY, Stamm WE, (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320: 204-210.
3. Campbell RJ, Giljahn L, Machesky K, Cibulskas-White K, Lane LM, et al. (2009) Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 30: 526-533.
4. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, et al. (2012) The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 107: 89-95.
5. Kutty PK, Woods CW, Sena AC, Benoit SR, Naggie S, et al. (2010) Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 16: 197-204.
6. Dumyati G, Stevens V, Hannett GE, Thompson AD, Long C, et al. (2012) Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg Infect Dis 18: 392-400.
7. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ, (2010) Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 31: 21-27.
8. Jinno S, Kundrapu S, Guerrero DM, Jury LA, Nerandzic MM, et al. (2012) Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection. Infect Control Hosp Epidemiol 33: 638-639.
9. Tescher AN, Branda ME, Byrne TJ, Naessens JM, (2012) All at-risk patients are not created equal: analysis of Braden pressure ulcer risk scores to identify specific risks. J Wound Ostomy Continence Nurs 39: 282-291.
10. Guerrero DM, Nerandzic MM, Jury LA, Jinno S, Chang S, et al. (2012) Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control 40: 556-558.
11. Dumford DM 3rd, Nerandzic MM, Eckstein BC, Donskey CJ (2009) What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control 37: 15-19.
12. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, et al. (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45: 992-998.
13. Boyce JM, Havill NL, Otter JA, Adams NM, (2007) Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol 28: 1142-1147.
14. Mayer RA, Geha RC, Helfand MS, Hoyen CK, Salata RA, et al. (2003) Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococci. Am J Infect Control 31: 221-225.
15. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA, (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46Suppl 1: S19-31.
16. Naggie S, Frederick J, Pien BC, Miller BA, Provenzale DT, et al. (2010) Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. Infection 38: 297-300.
17. Naggie S, Miller BA, Zuzak KB, Pence BW, Mayo AJ, et al. (2011) A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med 124: 276 e271-277.
18. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN, (2008) A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 62: 388-396.
19. Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, et al. (2008) Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 47: 56-62.